Advanced Medical Solutions develops and manufactures products for the surgical, wound care and wound closure markets. Its portfolio includes tissue adhesives, sutures, haemostats and advanced wound dressings, sold to hospitals and healthcare providers around the world, both under its own brands and through partners. …
Anpario develops, manufactures and sells feed additives designed to support animal health, nutrition and productivity, with a focus on natural products. Its range includes products that support gut health and help manage the effects of mycotoxins, which are toxins produced by moulds in animal …
AOTI develops and sells TWO2, a topical wound oxygen therapy system designed to treat chronic wounds such as diabetic foot ulcers. The therapy delivers oxygen directly to the wound surface and is intended for home use. The company, which operates primarily in the United …
Aptamer develops Optimer binders, engineered nucleic acid molecules designed as an alternative to antibodies. The company provides fee-for-service discovery and development work for pharmaceutical, diagnostics and biotechnology customers, and is increasingly seeking to license its technology so that it earns recurring, higher-margin income. Its …
Together, these updates suggest a company moving from platform development towards commercial relationships with established players in advanced therapies.
Abingdon Health develops and manufactures rapid diagnostic tests, particularly lateral flow tests, which give quick results from samples such as blood, saliva or urine. Much of itsBusinessinvolves providing contract development and manufacturing services to other organisations that want to bring their own tests to …
Diaceutics has disclosed a change in major ownership after Gresham House Asset Management increased its voting-rights position to 18.23%, from 17.02% previously. The change follows a period in which the precision-medicine commercialisation company has been highlighting strongerRecurring Revenuevisibility and expansion of its data-led platform.
Futura Medical reported positive results from an additional home-user test of its Eroxon Intense formulation and optimised presentation. The company says the revised presentation improved key user-reported performance measures compared with the earlier Intense presentation and the current Eroxon formulation, supporting plans for commercialisation …
Optima Health plc (LSE:OPT) has achieved transformative operational scale, establishing itself as the undisputedMarket Leaderin United Kingdom occupational health and employee clinical wellbeing services following its landmark admission to the London Stock Exchange's AIM market. The healthcare services group provides corporate occupational health assessments, …
Physiomics plc (LSE:PYC) continues to demonstrate operational progress in computational oncology, entering strategic collaborations and deploying its proprietary mathematical modeling software to optimize preclinical and clinicalDrug Developmentfor global biopharmaceutical clients. Quoted on the AIM market of the London Stock Exchange, the computational biology specialist …